These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
3350 related items for PubMed ID: 15475455
1. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells. Izeradjene K, Douglas L, Delaney A, Houghton JA. Clin Cancer Res; 2004 Oct 01; 10(19):6650-60. PubMed ID: 15475455 [Abstract] [Full Text] [Related]
2. Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex. Izeradjene K, Douglas L, Delaney AB, Houghton JA. Cancer Res; 2004 Nov 01; 64(21):8036-44. PubMed ID: 15520213 [Abstract] [Full Text] [Related]
3. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II. Ravi R, Bedi A. Cancer Res; 2002 Aug 01; 62(15):4180-5. PubMed ID: 12154014 [Abstract] [Full Text] [Related]
4. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways. Suliman A, Lam A, Datta R, Srivastava RK. Oncogene; 2001 Apr 19; 20(17):2122-33. PubMed ID: 11360196 [Abstract] [Full Text] [Related]
5. Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines. Izeradjene K, Douglas L, Tillman DM, Delaney AB, Houghton JA. Cancer Res; 2005 Aug 15; 65(16):7436-45. PubMed ID: 16103097 [Abstract] [Full Text] [Related]
6. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria. Zhang XD, Zhang XY, Gray CP, Nguyen T, Hersey P. Cancer Res; 2001 Oct 01; 61(19):7339-48. PubMed ID: 11585775 [Abstract] [Full Text] [Related]
7. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells. Sun SY, Yue P, Hong WK, Lotan R. Cancer Res; 2000 Dec 15; 60(24):7149-55. PubMed ID: 11156424 [Abstract] [Full Text] [Related]
8. IG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISC. Ramaswamy M, Efimova EV, Martinez O, Mulherkar NU, Singh SP, Prabhakar BS. Oncogene; 2004 Aug 12; 23(36):6083-94. PubMed ID: 15208670 [Abstract] [Full Text] [Related]
9. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5. Mitsiades N, Poulaki V, Mitsiades C, Tsokos M. Cancer Res; 2001 Mar 15; 61(6):2704-12. PubMed ID: 11289151 [Abstract] [Full Text] [Related]
10. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance. Ng CP, Zisman A, Bonavida B. Prostate; 2002 Dec 01; 53(4):286-99. PubMed ID: 12430140 [Abstract] [Full Text] [Related]
11. Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Zhang L, Fang B. Cancer Gene Ther; 2005 Mar 01; 12(3):228-37. PubMed ID: 15550937 [Abstract] [Full Text] [Related]
12. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release. Kandasamy K, Srinivasula SM, Alnemri ES, Thompson CB, Korsmeyer SJ, Bryant JL, Srivastava RK. Cancer Res; 2003 Apr 01; 63(7):1712-21. PubMed ID: 12670926 [Abstract] [Full Text] [Related]
13. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling. Chen X, Kandasamy K, Srivastava RK. Cancer Res; 2003 Mar 01; 63(5):1059-66. PubMed ID: 12615723 [Abstract] [Full Text] [Related]
14. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels. Nimmanapalli R, Perkins CL, Orlando M, O'Bryan E, Nguyen D, Bhalla KN. Cancer Res; 2001 Jan 15; 61(2):759-63. PubMed ID: 11212279 [Abstract] [Full Text] [Related]
15. Protein kinase C inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells. Shi RX, Ong CN, Shen HM. Cancer Res; 2005 Sep 01; 65(17):7815-23. PubMed ID: 16140950 [Abstract] [Full Text] [Related]
16. Defining characteristics of Types I and II apoptotic cells in response to TRAIL. Ozören N, El-Deiry WS. Neoplasia; 2002 Sep 01; 4(6):551-7. PubMed ID: 12407450 [Abstract] [Full Text] [Related]
17. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players. Hesry V, Piquet-Pellorce C, Travert M, Donaghy L, Jégou B, Patard JJ, Guillaudeux T. Prostate; 2006 Jun 15; 66(9):987-95. PubMed ID: 16541419 [Abstract] [Full Text] [Related]
18. Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors. Aggarwal BB, Bhardwaj U, Takada Y. Vitam Horm; 2004 Jun 15; 67():453-83. PubMed ID: 15110190 [Abstract] [Full Text] [Related]
19. Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathways. Shankar S, Singh TR, Fandy TE, Luetrakul T, Ross DD, Srivastava RK. Int J Mol Med; 2005 Dec 15; 16(6):1125-38. PubMed ID: 16273296 [Abstract] [Full Text] [Related]
20. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand. Mitsiades N, Poulaki V, Tseleni-Balafouta S, Koutras DA, Stamenkovic I. Cancer Res; 2000 Aug 01; 60(15):4122-9. PubMed ID: 10945619 [Abstract] [Full Text] [Related] Page: [Next] [New Search]